Association of Epstein-Barr Virus Reactivation with the Recovery of CD4/CD8 Double Negative T Lymphocytes after Haploidentical Hematopoietic Stem Cell Transplantation

被引:0
|
作者
Bian, Zhilei [1 ]
Liu, Jiangying [1 ]
Xu, Lan-Ping [1 ]
Chang, Ying-Jun [1 ]
Wang, Yu [1 ]
Zhang, Xiao-Hui [1 ]
Huang, Xiao-Jun [1 ,2 ]
机构
[1] Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China
[2] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
关键词
D O I
10.1182/blood.V128.22.5773.5773
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5773
引用
收藏
页数:5
相关论文
共 50 条
  • [21] CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1
    Lee, SP
    Brooks, JM
    Al-Jarrah, H
    Thomas, WA
    Haigh, RT
    Taylor, GS
    Humme, S
    Schepers, A
    Hammerschmidt, W
    Yates, JL
    Rickinson, AB
    Blake, NW
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10): : 1409 - 1420
  • [22] Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease
    Kohrt, Holbrook
    Johannsen, Alexandre
    Hoppe, Richard
    Horning, Sandra J.
    Rosenberg, Saul A.
    Advani, Ranjana
    Lee, Peter P.
    ONCOLOGY RESEARCH, 2009, 18 (5-6) : 287 - 292
  • [23] TRANSITION OF T-CELL RECEPTOR GAMMA/DELTA EXPRESSING DOUBLE-NEGATIVE (CD4(-)/CD8(-)) LYMPHOCYTES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    YABE, M
    YABE, H
    HATTORI, K
    HINOHARA, T
    MORIMOTO, T
    KATO, S
    KUSUNOKI, A
    BONE MARROW TRANSPLANTATION, 1994, 14 (05) : 741 - 746
  • [24] Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
    Z Peric
    X Cahu
    P Chevallier
    E Brissot
    F Malard
    T Guillaume
    J Delaunay
    S Ayari
    V Dubruille
    S Le Gouill
    B Mahe
    T Gastinne
    N Blin
    B Saulquin
    J-L Harousseau
    P Moreau
    N Milpied
    M Coste-Burel
    B-M Imbert-Marcille
    M Mohty
    Leukemia, 2011, 25 : 932 - 938
  • [25] Expansion of double negative (CD3+CD4-CD8-) T cells after stem cell transplantation
    Stachel, DK
    Schmid, I
    Schuster, F
    Haas, RJ
    PEDIATRIC RESEARCH, 1999, 45 (05) : 770 - 770
  • [26] Pre-emptive rituximab for Epstein-Barr virus reactivation after haplo-hematopoietic stem cell transplantation
    Kobayashi, Shogo
    Sano, Hideki
    Mochizuki, Kazuhiro
    Ohara, Yoshihiro
    Takahashi, Nobuhisa
    Ohto, Hitoshi
    Kikuta, Atsushi
    PEDIATRICS INTERNATIONAL, 2017, 59 (09) : 973 - 978
  • [27] Lymphocyte Cell Subsets Post Epstein-BARR Virus Reactivation may Predict Development of Post-Transplant Lymphoproliferative Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Children: CD8: CD20 Ratio as a Novel Marker
    Althubaiti, Sami
    Ali, Salah
    Krueger, Joerg
    Schechter, Tal
    Punnett, Angela Punnett
    Wall, Donna
    Ali, Muhammad
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S54 - S54
  • [28] Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
    Peric, Z.
    Cahu, X.
    Chevallier, P.
    Brissot, E.
    Malard, F.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Harousseau, J-L
    Moreau, P.
    Milpied, N.
    Coste-Burel, M.
    Imbert-Marcille, B-M
    Mohty, M.
    LEUKEMIA, 2011, 25 (06) : 932 - 938
  • [29] CD8 T cell priming by B lymphocytes is CD4 help dependent
    Castiglioni, P
    Gerloni, M
    Cortez-Gonzalez, X
    Zanetti, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) : 1360 - 1370
  • [30] Epstein–Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation
    Jiajia Hu
    Jie Zhao
    Chunyan Wang
    Mei Jia
    Ming Su
    Shanshan Li
    Annals of Hematology, 2023, 102 : 3593 - 3601